Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R, Méndez R, Palanques-Pastor T, Ballesta-López O, Borrás Almenar C, Megías Vericat JE, López-Briz E, Font-Noguera I, Menéndez Villanueva R, Román Iborra JA, Poveda Andrés JL.
Iglesias Gómez R, et al. Among authors: ballesta lopez o.
Eur J Hosp Pharm. 2022 Mar;29(e1):e41-e45. doi: 10.1136/ejhpharm-2021-002741. Epub 2021 Jul 28.
Eur J Hosp Pharm. 2022.
PMID: 34321249
Free PMC article.